Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: The Japanese-Brazilian thyroid study

European Journal of Endocrinology

Volumn 162, Issue 3, 2010, Pages 569-577

  Sgarbi, José A ^a,b   Matsumura, Luiza K ^a   Kasamatsu, Teresa S ^a   Ferreira, Sandra R ^a,c   Maciel, Rui M B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; SUBCLINICAL THYROID DYSFUNCTION; THYROID DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BRAZIL; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; THYROID DISEASES;

EID: 77149158454     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0845     Document Type: Article

References (51)

1. Surks MI & Ocampo E. Subclinical thyroid disease. American Journal of Medicine 1996 100 217-223.
2. Woeber KA. Subclinical thyroid dysfunction. Archives of Internal Medicine 1997 157 1065-1068.
3. Romaldini JH, Sgarbi JA & Farah CS. Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism. Arquivos Brasileiros de Endocrinologia e Metabologia 2004 48 147-158.
4. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T & Smith PA. The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology 1977 7 481-493.
5. Canaris GJ, Manowitz NR, Mayor G & Ridgway C. The Colorado thyroid disease prevalence study. Archives of Internal Medicine 2000 160 526-534.
6. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA & Braverman LE. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism 2002 87 489-499.
7. Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Service Task Force. Annals of Internal Medicine 2004 140 128-141.
8. Biondi B & Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews 2008 29 76-131.
9. Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bonè F, Lombardi G & Saccà L. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1999 84 2064-2067.
10. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C & Ferrannini E. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebocontrolled study. Journal of Clinical Endocrinology and Metabolism 2001 86 1110-1115.
11. Vitale G, Galderisi M, Lupoli GA, Celentano A, Pietropaolo I, Parenti N, De Divitiis O & Lupoli G. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. Journal of Clinical Endocrinology and Metabolism 2002 87 4350-4355.
12. Biondi B, Palmieri EA, Lombardi G & Fazio S. Effects of subclinical thyroid dysfunction on the heart. Annals of Internal Medicine 2002 137 904-914.
13. Aghini-Lombardi F, Di Bello V, Talini E, Di Cori A, Monzani F, Antonangeli L, Palagi C, Caraccio N, Grazia Delle Donne M, Nardi C, Dardano A, Balbarini A, Mariani M & Pinchera A. Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. European Journal of Endocrinology 2006 155 3-9.
14. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP, Ladenson PW, Vittinghoff E, Gottdiener JS & Newman AB. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. Journal of the American College of Cardiology 2008 52 1152-1159.
15. Akcakoyun M, Kaya H, Kargin R, Pala S, Emiroglu Y, Esen O, Karapinar H, Kaya Z & Esen AM. Abnormal left ventricular longitudinal functional reserve assessed by exercise pulsed wave tissue Doppler imaging in patients with subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2009 94 2979-2983.
16. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ & D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine 1994 331 1249-1252.
17. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F & Mariotti S. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. Journal of Clinical Endocrinology and Metabolism 2000 85 159-164.
18. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, Filetti S, Lombardi G & Perticone F. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism 2000 85 4701-4705.
19. Sgarbi JA, Villaça FG, Garbeline B, Villar HE & Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities. Journal of Clinical Endocrinology and Metabolism 2003 88 1672-1677.
20. Di Bello V, Aghini-Lombardi F, Monzani F, Talini E, Antonangeli L, Palagi C, Di Cori A, Caraccio N, Delle Donne MG, Dardano A, Pinchera A & Mariani M. Early abnormalities of left ventricular myocardial characteristics associated with subclinical hyperthyroidism. Journal of Endocrinological Investigation 2007 30 564-571.
21. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS & Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association 2004 291 228-238.
22. Gharib H, Tuttle M, Baskin HJ, Fish LH, Singer PA & McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Journal of Clinical Endocrinology and Metabolism 2005 90 581-585.
23. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865.
24. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S & Eguchi K. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2004 89 3365-3370.
25. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M & Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. Journal of the American Medical Association 2004 292 2591-2599.
26. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB & Bauer DC. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Archives of Internal Medicine 2005 165 2460-2466.
27. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE & Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 2005 90 6403-6409.
28. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P & Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine 2005 165 2467-2472.
29. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP & Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. Journal of the American Medical Association 2006 295 1033-1041.
30. Gimeno SG, Ferreira SR, Franco LJ, Hirai AT, Matsumura L & Moisés RS. Prevalence and 7-year incidence of type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 2002 45 1635-1638.
31. Friedewald WT, Levy RJ & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
32. Esteves RZ, Kasamatsu TS, Kunii IS, Furuzawa GK, Vieira JGH & Maciel RMB. Development of a semi-automated method for measuring urinary iodine and its application in epidemiological studies in Brazilian school children. Arquivos Brasileiros de Endocrinologia e Metabologia 2007 51 1477-1484.
33. Sacks D, Bakal CW, Beatty PT, Becker GJ, Cardella JF, Raabe RD, Wiener HM & Lewis CA. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the society of cardiovascular & interventional radiology. Journal of Vascular and Interventional Radiology 2002 13 353.
34. Haentjens P, Meerhaeghe AV, Poppe K & Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. European Journal of Endocrinology 2008 159 329-341.
35. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J & Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of Internal Medicine 2008 148 832-845.
36. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J & Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. American Journal of Medicine 2006 119 541-551.
37. Volzke H, Schwahn C, Wallaschofski H & Dorr M. Review: the association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? Journal of Clinical Endocrinology and Metabolism 2007 92 2421-2429.
38. Razvi S, Shakoor A, Vanderpump M, Weaver JU & Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2008 93 2998-3007.
39. Okamura K, Nakashima T, Ueda K, Inoue K, Omae T & Fujishima M. Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences. International Journal of Epidemiology 1987 16 545-549.
40. Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K & Murakami S. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodine determinations. Clinical Endocrinology 1993 38 273-281.
41. Sichieri R, Baima J, Henriques J, Vasconcellos M, Marante T, Kumagai S & Vaisman M. Prevalence of thyroid disease and positive antitiroperoxidase among 1,500 women 35 year old and older: a population-based survey in the city of Rio de Janeiro, Brazil. Thyroid 2005 15 S-42 (abs 118).
42. Camargo RY, Tomimori EK, Neves SC, Rubio IGS, Galrão AL, Knobel M & Medeiros-Neto G. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. European Journal of Endocrinology 2008 159 293-299.
43. Adler SM & Wartofsky L. The nonthyroidal illness syndrome. Endocrinology and Metabolism Clinics of North America 2007 36 657-672.
44. Sichieri R, Andrade R, Baima J, Henriques J & Vaisman M. TSH levels associated with slimming pill use in a population-based study of Brazilian women. Arquivos Brasileiros de Endocrinologia e Metabologia 2007 51 1448-1451.
45. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A & Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine 2000 132 270-278.
46. Takashima N, Niwa Y, Mannami T, Tomoike H & Iwai N. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints. The Suita Study. Circulation Journal 2007 71 191-195.
47. Danese MD, Ladenson PW, Meinert CL & Powe NR. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. Journal of Clinical Endocrinology and Metabolism 2000 85 2993-3001.
48. Villar HCCE, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism (Cochrane Review CD003419). In: The Cochrane Library, Issue 3, 2007.
49. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C & Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. Journal of Clinical Endocrinology and Metabolism 2007 92 1715-1723.
50. Vanderpump MP, Tunbridge WM, French JM, Appleton B, Bates D, Clark F, Grimley Evans J, Rodgers H, Tunbridge F & Young ET. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996 6 155-160.
51. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP & Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. International Journal of Cardiology 2008 125 41-48.